{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T06:12:07Z","timestamp":1776147127333,"version":"3.50.1"},"reference-count":35,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T00:00:00Z","timestamp":1776124800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Mechanical circulatory support technology, particularly continuous-flow left ventricular assist devices (CF-LVADs), has emerged as a vital therapeutic option for end-stage heart failure (ESHF). However, domestic data on the long-term efficacy and safety of CF-LVADs in real-world settings remain limited, necessitating further investigation to guide clinical practice.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This single-center, retrospective study analyzed 28 patients who underwent CF-LVAD implantation as destination therapy for ESHF between October 2022 and July 2025. One patient died intraoperatively due to severe cardiogenic shock and was excluded from subsequent analyses. The remaining 27 patients (median age: 61 years; 88.9% male) were followed for a median duration of 5.4 months (range: 1.1\u201335.4 months). Perioperative clinical characteristics, early- and late-term outcomes, including survival, readmission rates, and changes in cardiac and renal\/hepatic function, were evaluated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>During the follow-up period, significant improvements of liver and renal function were observed, as well as a reduced left ventricular end-diastolic diameter, and an increased left ventricular ejection fraction. Despite these improvements, two deaths occurred during CF-LVAD support, and the hospital readmission rate reached 40.74%.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>CF-LVADs demonstrated promising efficacy in improving hemodynamic and organ function in patients with ESHF. However, the notable readmission rate and mortality highlight the need for optimized patient selection, postoperative management, and long-term monitoring. This study provides critical insights into the real-world challenges and benefits of CF-LVAD therapy, underscoring its value as destination therapy while calling for larger, multicenter studies to validate these findings and further refine clinical protocols.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fcvm.2026.1784700","type":"journal-article","created":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T05:36:25Z","timestamp":1776144985000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Perioperative clinical profiles and longitudinal outcomes in patients supported by continuous-flow left ventricular assist devices: a comprehensive analysis of early and late follow-up data"],"prefix":"10.3389","volume":"13","author":[{"given":"Qiuju","family":"Ding","sequence":"first","affiliation":[{"name":"Department of Cardio-thoracic Surgery, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School","place":["Nanjing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingqing","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Cardio-thoracic Surgery, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School","place":["Nanjing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zeyi","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Cardio-thoracic Surgery, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School","place":["Nanjing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Cardio-thoracic Surgery, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School","place":["Nanjing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenjun","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Cardio-thoracic Surgery, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School","place":["Nanjing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Pan","sequence":"additional","affiliation":[{"name":"Department of Cardio-thoracic Surgery, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School","place":["Nanjing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Ge","sequence":"additional","affiliation":[{"name":"Department of Cardio-thoracic Surgery, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School","place":["Nanjing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,4,14]]},"reference":[{"key":"B1","first-page":"10","article-title":"Epidemiology, etiology and pathophysiology of heart failure","volume":"39","author":"Linicus","year":"2016","journal-title":"Med Monatsschr Pharm"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1002\/ejhf.1236","article-title":"Advanced heart failure: a position statement of the heart failure association of the European society of cardiology","volume":"20","author":"Crespo-Leiro","year":"2018","journal-title":"Eur J Heart Fail"},{"key":"B3","doi-asserted-by":"publisher","first-page":"2241","DOI":"10.1056\/NEJMoa0909938","article-title":"Advanced heart failure treated with continuous-flow left ventricular assist device","volume":"361","author":"Slaughter","year":"2009","journal-title":"N Engl J Med"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1001\/jama.2022.16197","article-title":"Five-year outcomes in patients with fully magnetically levitated vs. axial-flow left ventricular assist devices in the MOMENTUM 3 randomized trial","volume":"328","author":"Mehra","year":"2022","journal-title":"Jama"},{"key":"B5","doi-asserted-by":"publisher","first-page":"7813","DOI":"10.3390\/jcm13247813","article-title":"Advancing LVAD technology: overcoming challenges and shaping the future of mechanical circulatory support","volume":"13","author":"Kozakov","year":"2024","journal-title":"J Clin Med"},{"key":"B6","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.jacc.2009.03.055","article-title":"Extended mechanical circulatory support with a continuous-flow rotary left ventricular assist device","volume":"54","author":"Pagani","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1890","DOI":"10.1016\/j.jacc.2010.10.062","article-title":"Results of the post-U.S. food and drug administration-approval study with a continuous flow left ventricular assist device as a bridge to heart transplantation: a prospective study using the INTERMACS (interagency registry for mechanically assisted circulatory support)","volume":"57","author":"Starling","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.healun.2012.12.004","article-title":"Fifth INTERMACS annual report: risk factor analysis from more than 6,000 mechanical circulatory support patients","volume":"32","author":"Kirklin","year":"2013","journal-title":"J Heart Lung Transplant"},{"key":"B9","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.healun.2012.11.010","article-title":"Impact of long term left ventricular assist device therapy on donor allocation in cardiac transplantation","volume":"32","author":"Uriel","year":"2013","journal-title":"J Heart Lung Transplant"},{"key":"B10","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.healun.2022.12.004","article-title":"The 2023 international society for heart and lung transplantation guidelines for mechanical circulatory support: a 10- year update","volume":"42","author":"Saeed","year":"2023","journal-title":"J Heart Lung Transplant"},{"key":"B11","doi-asserted-by":"publisher","first-page":"e15","DOI":"10.1053\/j.jvca.2012.11.009","article-title":"The vasoactive-inotropic score and levosimendan: time for LVIS?","volume":"27","author":"Favia","year":"2013","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"B12","doi-asserted-by":"publisher","first-page":"3191","DOI":"10.1161\/CIRCULATIONAHA.111.058412","article-title":"Use of an intrapericardial, continuous-flow, centrifugal pump in patients awaiting heart transplantation","volume":"125","author":"Aaronson","year":"2012","journal-title":"Circulation"},{"key":"B13","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1161\/CIRCHEARTFAILURE.111.963991","article-title":"Outcomes in advanced heart failure patients with left ventricular assist devices for destination therapy","volume":"5","author":"Park","year":"2012","journal-title":"Circ Heart Fail"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1056\/NEJMoa012175","article-title":"Long-term use of a left ventricular assist device for end-stage heart failure","volume":"345","author":"Rose","year":"2001","journal-title":"N Engl J Med"},{"key":"B15","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.jacc.2012.09.041","article-title":"Readmissions after implantation of axial flow left ventricular assist device","volume":"61","author":"Hasin","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"2316","DOI":"10.1161\/CIRCULATIONAHA.115.017647","article-title":"Restoration of pulsatile flow reduces sympathetic nerve activity among individuals with continuous-flow left ventricular assist devices","volume":"132","author":"Cornwell","year":"2015","journal-title":"Circulation"},{"key":"B17","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.tcm.2017.07.002","article-title":"Arrhythmias after left ventricular assist device implantation: incidence and management","volume":"28","author":"Kadado","year":"2018","journal-title":"Trends Cardiovasc Med"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1016\/j.hrthm.2021.03.047","article-title":"Electrical storm in patients with left ventricular assist devices: risk factors, incidence, and impact on survival","volume":"18","author":"Rehorn","year":"2021","journal-title":"Heart Rhythm"},{"key":"B19","doi-asserted-by":"publisher","first-page":"2542","DOI":"10.1016\/j.jacc.2013.04.020","article-title":"Ventricular arrhythmias and implantable cardioverter-defibrillator therapy in patients with continuous-flow left ventricular assist devices: need for primary prevention?","volume":"61","author":"Garan","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1016\/j.jtcvs.2012.03.061","article-title":"Cryoablation during left ventricular assist device implantation reduces postoperative ventricular tachyarrhythmias","volume":"145","author":"Mulloy","year":"2013","journal-title":"J Thorac Cardiovasc Surg"},{"key":"B21","doi-asserted-by":"publisher","first-page":"ofaa124","DOI":"10.1093\/ofid\/ofaa124","article-title":"In full flow: left ventricular assist device infections in the modern era","volume":"7","author":"Zinoviev","year":"2020","journal-title":"Open Forum Infect Dis"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1016\/j.jacc.2010.05.016","article-title":"Acquired von Willebrand syndrome after continuous-flow mechanical device support contributes to a high prevalence of bleeding during long-term support and at the time of transplantation","volume":"56","author":"Uriel","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1161\/CIRCHEARTFAILURE.112.000206","article-title":"Pulsatility and the risk of nonsurgical bleeding in patients supported with the continuous-flow left ventricular assist device HeartMate II","volume":"6","author":"Wever-Pinzon","year":"2013","journal-title":"Circulation Heart Failure"},{"key":"B24","doi-asserted-by":"publisher","first-page":"2162","DOI":"10.1016\/j.jacc.2009.02.048","article-title":"Severely impaired von Willebrand factor-dependent platelet aggregation in patients with a continuous-flow left ventricular assist device (HeartMate II)","volume":"53","author":"Klovaite","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1161\/CIRCULATIONAHA.117.028303","article-title":"Hemocompatibility-related outcomes in the MOMENTUM 3 trial at 6 months: a randomized controlled study of a fully magnetically levitated pump in advanced heart failure","volume":"135","author":"Uriel","year":"2017","journal-title":"Circulation"},{"key":"B26","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.jtcvs.2015.09.052","article-title":"Adverse event burden and mechanical circulatory support: looking toward the future","volume":"151","author":"Pagani","year":"2016","journal-title":"J Thorac Cardiovasc Surg"},{"key":"B27","doi-asserted-by":"publisher","first-page":"348","DOI":"10.2215\/CJN.04670417","article-title":"Left ventricular assist devices and the kidney","volume":"13","author":"Ross","year":"2018","journal-title":"Clin J Am Soc Nephrol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1159\/000358495","article-title":"Acute kidney injury and mortality following ventricular assist device implantation","volume":"39","author":"Naik","year":"2014","journal-title":"Am J Nephrol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1016\/j.cardfail.2009.05.015","article-title":"Predictors of acute renal dysfunction after ventricular assist device placement","volume":"15","author":"Alba","year":"2009","journal-title":"J Card Fail"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.healun.2016.10.001","article-title":"PREVENtion of HeartMate II pump thrombosis through clinical management: the PREVENT multi-center study","volume":"36","author":"Maltais","year":"2017","journal-title":"J Heart Lung Transplant"},{"key":"B31","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1007\/s10741-015-9481-z","article-title":"Left ventricular assist devices: a kidney\u2019s perspective","volume":"20","author":"Tromp","year":"2015","journal-title":"Heart Fail Rev"},{"key":"B32","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1016\/j.healun.2007.05.012","article-title":"End-organ function in patients on long-term circulatory support with continuous- or pulsatile-flow assist devices","volume":"26","author":"Radovancevic","year":"2007","journal-title":"J Heart Lung Transplant"},{"key":"B33","doi-asserted-by":"publisher","first-page":"2352","DOI":"10.1161\/CIRCULATIONAHA.108.814863","article-title":"Renal and hepatic function improve in advanced heart failure patients during continuous-flow support with the HeartMate II left ventricular assist device","volume":"120","author":"Russell","year":"2009","journal-title":"Circulation"},{"key":"B34","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.xkme.2021.01.009","article-title":"Kidney function following left ventricular assist device implantation: an observational cohort study","volume":"3","author":"Wettersten","year":"2021","journal-title":"Kidney Med"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1080\/03007995.2021.1948395","article-title":"A varied approach to left ventricular assist device follow-up improves cost-effectiveness","volume":"37","author":"Ahmed","year":"2021","journal-title":"Curr Med Res Opin"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2026.1784700\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T05:36:28Z","timestamp":1776144988000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2026.1784700\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,14]]},"references-count":35,"alternative-id":["10.3389\/fcvm.2026.1784700"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2026.1784700","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,14]]},"article-number":"1784700"}}